Eastman (NYSE: EMN) Q1 2026 revenue falls 5% but Q2 EPS seen higher
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Eastman Chemical Company reported first-quarter 2026 results with sales revenue of $2,177 million, down 5% from $2,290 million a year earlier, and diluted EPS of $0.93 versus $1.57. Adjusted EBIT was $200 million compared with $311 million, and adjusted EPS was $1.09 versus $1.91.
EBIT fell to $188 million from $302 million, driven by weaker spreads in Chemical Intermediates, lower volume in Fibers, lower asset utilization in Advanced Materials, and higher energy costs, partially offset by cost reductions and an expected tariff refund. Cash used in operating activities improved to $137 million from $167 million as the company built inventory ahead of planned shutdowns and returned $96 million in dividends.
Management is implementing about $500 million of price increases and targeting $125–$150 million of net cost savings in 2026, with capital spending of approximately $400 million. They expect significantly higher 2026 earnings versus 2025 and project second-quarter 2026 adjusted diluted EPS between $1.70 and $1.90, helped by margin improvement in Chemical Intermediates and stronger specialty volume.
Positive
- None.
Negative
- None.
Insights
Q1 2026 was weaker year over year but supports a more optimistic 2026 earnings outlook.
Eastman delivered Q1 2026 sales of $2,177 million, down 5%, with reported EBIT of $188 million and adjusted EBIT of $200 million versus $311 million a year earlier. Earnings pressure came mainly from weaker Chemical Intermediates spreads and a sharp Fibers downturn.
Specialty segments were mixed: Advanced Materials sales slipped 1% with margin compression from lower asset utilization, while Additives & Functional Products grew sales 1% and held adjusted EBIT margin at 19.2%. Management highlighted more than 10% sequential volume/mix improvement in specialty businesses and ongoing cost-reduction initiatives.
Looking ahead, the company plans about $500 million in price increases and $125–$150 million in net cost savings for 2026, with capital expenditures around $400 million. They see tightening markets benefiting Chemical Intermediates and guide Q2 2026 adjusted EPS to $1.70–$1.90, up from $1.09 in Q1, implying a stronger earnings trajectory if execution and macro conditions hold.
8-K Event Classification
4 items: 2.02, 8.8, 9.01, 10.9
4 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 8.8
Item 8.8
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Item 10.9
Item 10.9
Key Figures
Sales revenue: $2,177 million
Reported EBIT: $188 million
Diluted EPS: $0.93
+5 more
8 metrics
Sales revenue
$2,177 million
Q1 2026 vs $2,290 million in Q1 2025 (down 5%)
Reported EBIT
$188 million
Q1 2026 vs $302 million in Q1 2025
Diluted EPS
$0.93
Q1 2026 vs $1.57 in Q1 2025
Adjusted EPS
$1.09
Q1 2026 vs $1.91 in Q1 2025
Net cash used in operating activities
$137 million
Q1 2026 vs $167 million in Q1 2025
Net debt
$4,555 million
As of March 31, 2026
Cost savings target
$125–$150 million
Planned net cost reduction in 2026
Q2 2026 adjusted EPS guidance
$1.70–$1.90
Projected adjusted diluted EPS for second quarter 2026
Key Terms
Adjusted EBIT, International Emergency Economic Powers Act, methanolysis facility, mark-to-market pension, +1 more
5 terms
Adjusted EBIT financial
"Adjusted EBIT* | 200 | 311"
Adjusted EBIT is a company’s operating profit before interest and taxes, but cleaned up by removing one-time or unusual items that can obscure ongoing performance. Investors use it like a tidied-up report card — it aims to show the underlying profitability of the business by excluding irregular gains, losses, or costs so comparisons across periods or companies are clearer and more meaningful for valuing operational strength.
International Emergency Economic Powers Act regulatory
"recognition of an expected refund for tariffs paid under the International Emergency Economic Powers Act"
A U.S. law that gives the president broad authority to control trade, financial transactions, and assets during a declared national emergency, such as by imposing sanctions, freezing property, or restricting exports and imports. For investors it matters because those powers can suddenly block deals, cut off access to markets or funds, and change the value of companies or securities much like an emergency brake that can stop or reroute economic activity overnight.
methanolysis facility technical
"commercial ramp up of the Kingsport methanolysis facility and remain on track"
mark-to-market pension financial
"Mark-to-market pension and other postretirement benefit plans (gain) loss, net"
non-GAAP financial
"this press release includes the following non-GAAP financial measures"
Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.
Earnings Snapshot
Sales revenue: $2,177 million · Guidance included
Q1 2026
Sales revenue
$2,177 million
-5% YoY
Diluted EPS
$0.93
down from $1.57 in Q1 2025
Adjusted EPS
$1.09
down from $1.91 in Q1 2025
Adjusted EBIT
$200 million
down from $311 million in Q1 2025
Guidance
Management expects significantly improved 2026 earnings versus 2025 and projects second-quarter 2026 adjusted diluted EPS in the range of $1.70 to $1.90.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
(Exact Name of Registrant as Specified in Its Charter)
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| (Address of Principal Executive Offices) | (Zip Code) | |||||||
(423 ) 229-2000
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||||||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||||||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||||||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||||||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| EASTMAN CHEMICAL COMPANY - EMN | ||||||||
Item 2.02 Results of Operations and Financial Condition
On April 30, 2026, the registrant publicly released its financial results for first quarter 2026. The full text of the release is furnished as Exhibit 99.01 to this Current Report on Form 8-K, and is incorporated herein by reference. This information shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits:
(d) Exhibits
The following exhibits are furnished pursuant to Item 9.01:
99.01 Public release by Eastman on April 30, 2026 of first quarter 2026 financial results
104 Cover Page Interactive Data File
| EASTMAN CHEMICAL COMPANY - EMN | ||||||||
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
Eastman Chemical Company | ||||||||
| By: | /s/ Michelle R. Stewart | |||||||
| Michelle R. Stewart | ||||||||
| Vice President, Chief Accounting Officer and Corporate Controller | ||||||||
Date: April 30, 2026 | ||||||||
Exhibit 99.01
Eastman Announces First-Quarter 2026 Financial Results
KINGSPORT, Tenn., April 30, 2026 – Eastman Chemical Company (NYSE:EMN) announced its first-quarter 2026 financial results.
•Delivered strong sequential sales volume/mix improvement of >10 percent in specialty businesses
•Implementing ~$500 million of price increases across the portfolio to offset substantial raw material and distribution inflation
•Leveraging our integrated U.S.-based assets and global reach to be a reliable supplier to our customers amid a dynamic global environment
•On track with methanolysis facility revenue acceleration and ~$30 million of incremental earnings
•Drove 240 basis points of sequential adjusted EBIT margin improvement through improved sales volumes and disciplined price-cost management
•Maintained strong momentum towards key financial priorities, including year-over-year earnings growth, our $125 million to $150 million of cost savings and our cash flow targets
| (In millions, except per share amounts; unaudited) | 1Q2026 | 1Q2025 | ||||||
| Sales revenue | $2,177 | $2,290 | ||||||
| Earnings before interest and taxes ("EBIT") | 188 | 302 | ||||||
| Adjusted EBIT* | 200 | 311 | ||||||
| Earnings per diluted share | 0.93 | 1.57 | ||||||
| Adjusted earnings per diluted share* | 1.09 | 1.91 | ||||||
Net cash used in operating activities | (137) | (167) | ||||||
*For non-core and unusual items excluded from adjusted earnings and for adjusted provision for income taxes, segment adjusted EBIT margins, and net debt, reconciliations to reported company and segment earnings and total borrowings for all periods presented in this release, see Tables 3A, 3B, 4A, and 6.
“We delivered a solid first quarter that was in line with our expectations for both earnings and cash flow,” said Mark Costa, Board Chair and CEO. “I am proud of the way we took immediate steps to position our company to create opportunities and navigate yet another significant disruption in our industry. As global markets reacted to the conflict in the Middle East, the Eastman team quickly took decisive actions to secure supply for crucial raw materials, adjust prices where necessary, and partner with our customers to help them navigate this uncertainty. Sales volume/mix increased 10 percent sequentially as demand improved due to normal seasonality and reduced caution from customers after year-end inventory management. Altogether, volumes built momentum through the end of the quarter and continue to be strong. We also made solid progress in the commercial ramp up of the Kingsport methanolysis facility and remain on track for our operational and financial goals.”
Corporate Results 1Q 2026 versus 1Q 2025
Sales revenue decreased 5 percent as 4 percent lower sales volume/mix and 4 percent lower selling prices were offset by a 3 percent favorable foreign currency exchange impact.
Lower sales volume/mix was primarily driven by customer inventory destocking in the acetate tow product line as well as continued weak underlying demand for consumer discretionary end markets. Lower selling prices were due to lower raw material prices and continued weak commodity market conditions in Chemical Intermediates.
EBIT decreased due to lower spreads in Chemical Intermediates, lower sales volume/mix in Fibers, lower asset utilization in Advanced Materials, and increased energy costs across our businesses resulting from Winter Storm Fern. These factors were partially offset by the benefits of continued cost-reduction initiatives and recognition of an expected refund for tariffs paid under the International Emergency Economic Powers Act.
Segment Results 1Q 2026 versus 1Q 2025
Advanced Materials – Sales revenue decreased 1 percent due to 4 percent lower selling prices partially offset by a 3 percent favorable foreign currency exchange impact.
Selling prices declined due to lower raw material prices. Sales volume/mix was unchanged as strong growth in specialty plastics was offset by weakness in performance films due to a soft automotive aftermarket.
EBIT decreased primarily due to substantially lower asset utilization driven by differences in building inventory last year and reducing inventory this year. Price-cost was also modestly lower. These factors were partially offset by continued cost-reduction initiatives.
Additives & Functional Products – Sales revenue increased by 1 percent due to a 4 percent favorable foreign currency exchange impact, partially offset by 2 percent lower selling prices and 1 percent lower sales volume/mix.
Lower selling prices were primarily driven by cost-pass-through contracts. Lower sales volume/mix was primarily due to lower demand for coatings additives in the building and construction end market and a few discontinued products, partially offset by growth in pharma and aviation.
EBIT was relatively unchanged due to a favorable foreign currency exchange impact, mostly offset by modest price declines.
Fibers – Sales revenue decreased by 22 percent due to 19 percent lower sales volume/mix and 3 percent lower selling prices.
Lower sales volume/mix was driven by continued customer inventory destocking in acetate tow and the impact of the conflict in the Middle East, resulting in some reduced customer shipments. Textiles sales volume/mix was also lower due to continued weakness in the underlying end market. Lower selling prices were due to modestly lower contract pricing compared to 2025.
EBIT declined due to substantially lower sales volume/mix, lower price-cost due to modestly lower selling prices and higher energy costs, and lower asset utilization.
Chemical Intermediates – Sales revenue decreased by 9 percent due to 7 percent lower selling prices and 3 percent lower sales volume/mix, partially offset by a 1 percent favorable foreign currency exchange impact.
In January and February, lower selling prices and lower sales volume/mix were driven by continued weak commodity market conditions compared to the prior-year period. In March, the Middle East conflict began to tighten market conditions for some olefin and derivative products.
EBIT decreased due to lower spreads, partially offset by continued cost reduction initiatives.
Cash Flow
In first quarter 2026, cash used in operating activities was $137 million versus $167 million in first quarter 2025. Inventory increased to prepare for large, planned shutdowns in second quarter 2026. The company returned $96 million to stockholders through dividends. See Table 5. Priorities for uses of available cash for 2026 include payment of the quarterly dividend, capital expenditures, and share repurchases while maintaining our solid investment-grade balance sheet.
2026 Outlook
Commenting on the outlook for full-year 2026, Costa said: “The Middle East conflict is a significant disruption for our industry, which is likely to create net upside to our earnings. Compared to January, the most visible change is in Chemical Intermediates, where tightening market conditions are quickly and substantially improving margins. In our specialty businesses, we are raising prices to offset higher raw material and distribution costs and offset those costs as we go through the year. We also see potential volume/mix upsides where our U.S. asset footprint enables security of supply for our customers. Of course, we don’t know how long this conflict will last and what impact it might have on consumer demand. For now, we are planning for stable demand compared to 2025 in our consumer discretionary end markets, except for automotive, which we expect will decline by low-single-digits. In this context, we continue to focus on what we can control and actions that we can take to consistently serve the market with our advantaged North American assets. We expect meaningful growth from our innovation-driven growth model, led by new wins in our Renew product lines produced at our Kingsport methanolysis facility. We remain on track to reduce costs by between $125 million and $150 million, net of inflation, and are maintaining disciplined capital expenditures by spending approximately $400 million this year. We also continue to expect tailwinds from lower shutdown expense, improved asset utilization, and favorable foreign currency exchange rates. When putting all of these factors together, we remain confident we can significantly improve earnings in 2026 versus 2025. On cash, the inflationary environment is putting pressure on working capital. We see a pathway for operating cash flow to approach 2025 levels while recognizing that this pathway is narrowing in the current environment.
“Looking specifically at the sequential second-quarter outlook, we expect tailwinds from improved sales volume/mix in Advanced Materials and, to a lesser extent, Additives & Functional Products, as well as substantial spread improvement in Chemical Intermediates. We expect specialty price increases to keep pace with higher raw material and distribution costs through the quarter. Headwinds include approximately $45 million of costs from planned maintenance. When putting these factors together, we project second-quarter adjusted EPS to be in the range of $1.70 to $1.90.”
The second-quarter 2026 projected adjusted diluted EPS excludes any non-core, unusual, or nonrecurring items. Our financial results forecasts do not include non-core items (such as mark-to-market pension and other post-retirement benefit gain or loss, and asset impairments and restructuring charges) or any unusual or non-recurring items because we are unable to predict with reasonable certainty the financial impact of such items. These items are uncertain and depend on various factors, and we are unable to reconcile projected adjusted diluted EPS excluding non-core and any unusual or non-recurring items to reported GAAP diluted EPS without unreasonable efforts.
Forward-Looking Statements
The information in this release and other statements by the company may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to, among other items: projections and estimates of earnings, revenues, volumes, pricing, margins, cost reductions, expenses, taxes, liquidity, capital expenditures, cash flow, dividends, share repurchases or other financial items, statements of management’s plans, strategies and objectives for future operations, and statements regarding future economic, industry or market conditions or performance. Such projections and estimates are based upon certain preliminary information, internal estimates, and management assumptions, expectations, and plans. Forward-looking statements are subject to a number of risks and uncertainties, and actual performance or results could differ materially from that anticipated by any forward-looking statements. Forward-looking statements speak only as of the date they are made, and the company undertakes no obligation to update or revise any forward-looking statement. Other important assumptions and factors that could cause actual results to differ materially from those in the forward-looking statements are detailed in the sections entitled "Risk Factors" and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" in the company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, and as updated in the company’s filings with the Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov and the company’s website at www.eastman.com.
Financial Measures (Non-GAAP)
In addition to the financial information presented in accordance with Generally Accepted Accounting Principles ("GAAP"), this press release includes the following non-GAAP financial measures: adjusted EBIT, adjusted EBIT margin, and adjusted earnings per diluted share. We define adjusted EBIT as the GAAP measure EBIT adjusted for non-core, unusual, or non-recurring items. Adjusted earnings per diluted share is defined as the GAAP measure earnings per diluted share adjusted for non-core, unusual, or non-recurring items. Adjusted EBIT margin is defined as adjusted EBIT divided by the GAAP measure sales revenue in the Company's Unaudited Consolidated Statement of Earnings, Comprehensive Income and Retained Earnings for the same periods. See the reconciliation tables presented in this release for a detailed reconciliation of non-GAAP financial measures to the most directly comparable GAAP measure.
We believe that in addition to our results determined in accordance with GAAP, these non-GAAP financial measures provide useful information to both management and investors in measuring our financial performance and highlight trends in our business that may not otherwise be apparent when relying solely on GAAP measures. These non-GAAP financial measures provide supplemental information regarding our operating performance that excludes certain gains, losses and non-cash charges that occur relatively infrequently and/or that we consider to be unrelated to our core operations. Non-GAAP financial information is presented for supplemental informational purposes only and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Our presentation of non-GAAP measures should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items. Other companies in our industry may calculate these measures differently, which may limit their usefulness as comparative measures.
Conference Call and Webcast Information
Eastman will host a conference call with industry analysts on May 1, 2026, at 8:00 a.m. ET. To listen to the live webcast of the conference call and view the accompanying slides and prepared remarks, go to investors.eastman.com, Events & Presentations. The slides and prepared remarks to be discussed during the call and webcast will be available at investors.eastman.com at approximately 4:15 p.m. ET on April 30, 2026. To listen via telephone, the dial-in number is +1 (833) 470-1428, passcode: 402297. A web replay, a replay in downloadable MP3 format, and the accompanying slides and prepared remarks will be available at investors.eastman.com, Events & Presentations. A telephone replay will be available continuously beginning at approximately 1:00 p.m. Eastern Time, May 1, 2026, through 11:59 p.m. Eastern Time, May 10, 2026, Toll Free at +1 (866) 813-9403, passcode 531385.
Founded in 1920, Eastman is a global specialty materials company that produces a broad range of products found in items people use every day. With the purpose of enhancing the quality of life in a material way, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and sustainability. The company’s innovation-driven growth model takes advantage of world-class technology platforms, deep customer engagement, and differentiated application development to grow its leading positions in attractive end markets such as transportation, building and construction, and consumables. As a globally inclusive company, Eastman employs approximately 13,000 people around the world and serves customers in more than 100 countries. The company had 2025 revenue of approximately $8.8 billion and is headquartered in Kingsport, Tennessee, USA. For more information, visit www.eastman.com.
# # #
Contacts:
Media: Tracy Kilgore Addington
423-224-0498 / tracy@eastman.com
Investors: Greg Riddle
212-835-1620 / griddle@eastman.com
FINANCIAL INFORMATION
April 30, 2026
For Eastman Chemical Company First Quarter and Full Year 2026 Financial Results Release
Table of Contents
| Item | Page | |||||||
Table 1 | Statements of Earnings | 1 | ||||||
Table 2A | Segment Sales Information | 2 | ||||||
Table 2B | Sales Revenue Change | 3 | ||||||
Table 2C | Sales by Customer Location | 3 | ||||||
Table 3A | Segment, Other, and Company Non-GAAP Earnings (Loss) Before Interest and Taxes Reconciliations | 4 | ||||||
Table 3B | Segment Non-GAAP Earnings (Loss) Before Interest and Taxes Margins | 6 | ||||||
Table 4A | Non-GAAP Earnings Before Interest and Taxes, Net Earnings, and Earnings Per Share Reconciliations | 7 | ||||||
Table 4B | Adjusted Effective Tax Rate Calculation | 8 | ||||||
Table 5 | Statements of Cash Flows | 9 | ||||||
Table 6 | Total Borrowings to Net Debt Reconciliations | 9 | ||||||
Table 1 – Statements of Earnings
| First Quarter | |||||||||||
| (Dollars in millions, except per share amounts; unaudited) | 2026 | 2025 | |||||||||
| Sales | $ | 2,177 | $ | 2,290 | |||||||
Cost of sales (1) | 1,746 | 1,723 | |||||||||
| Gross profit | 431 | 567 | |||||||||
| Selling, general and administrative expenses | 178 | 182 | |||||||||
| Research and development expenses | 60 | 67 | |||||||||
| Asset impairments, restructuring, and other charges, net | 9 | 9 | |||||||||
| Other components of post-employment (benefit) cost, net | (17) | (1) | |||||||||
| Other (income) charges, net | 13 | 8 | |||||||||
| Earnings before interest and taxes | 188 | 302 | |||||||||
| Net interest expense | 52 | 49 | |||||||||
| Earnings before income taxes | 136 | 253 | |||||||||
| Provision for income taxes | 29 | 70 | |||||||||
| Net earnings | 107 | 183 | |||||||||
| Less: Net earnings attributable to noncontrolling interest | — | 1 | |||||||||
| Net earnings attributable to Eastman | $ | 107 | $ | 182 | |||||||
| Basic earnings per share attributable to Eastman | $ | 0.93 | $ | 1.58 | |||||||
| Diluted earnings per share attributable to Eastman | $ | 0.93 | $ | 1.57 | |||||||
| Shares (in millions) outstanding at end of period | 114.3 | 115.5 | |||||||||
| Shares (in millions) used for earnings per share calculation | |||||||||||
| Basic | 114.2 | 115.2 | |||||||||
| Diluted | 115.0 | 116.5 | |||||||||
(1)First quarter 2026 includes inventory adjustment charges of $3 million related to the closure of a production line at a German performance films facility in the Advanced Materials ("AM") segment.
1
Table 2A – Segment Sales Information
| First Quarter | |||||||||||
| (Dollars in millions, unaudited) | 2026 | 2025 | |||||||||
| Sales by Segment | |||||||||||
| Advanced Materials | $ | 715 | $ | 719 | |||||||
Additives & Functional Products | 739 | 733 | |||||||||
Chemical Intermediates | 495 | 545 | |||||||||
| Fibers | 225 | 288 | |||||||||
| Total Sales by Segment | 2,174 | 2,285 | |||||||||
Other | 3 | 5 | |||||||||
| Total Eastman Chemical Company | $ | 2,177 | $ | 2,290 | |||||||
| Fourth Quarter | |||||
| (Dollars in millions, unaudited) | 2025 | ||||
| Sales by Segment | |||||
| Advanced Materials | $ | 656 | |||
Additives & Functional Products | 662 | ||||
Chemical Intermediates | 418 | ||||
| Fibers | 234 | ||||
| Total Sales by Segment | 1,970 | ||||
Other | 3 | ||||
| Total Eastman Chemical Company | $ | 1,973 | |||
2
Table 2B – Sales Revenue Change
First Quarter 2026 Compared to First Quarter 2025 | ||||||||||||||
| Change in Sales Revenue Due To | ||||||||||||||
| (Unaudited) | Revenue % Change | Volume / Product Mix Effect | Price Effect | Exchange Rate Effect | ||||||||||
| Advanced Materials | (1) | % | — | % | (4) | % | 3 | % | ||||||
| Additives & Functional Products | 1 | % | (1) | % | (2) | % | 4 | % | ||||||
| Chemical Intermediates | (9) | % | (3) | % | (7) | % | 1 | % | ||||||
| Fibers | (22) | % | (19) | % | (3) | % | — | % | ||||||
Total Eastman Chemical Company | (5) | % | (4) | % | (4) | % | 3 | % | ||||||
First Quarter 2026 Compared to Fourth Quarter 2025 | ||||||||||||||
| Change in Sales Revenue Due To | ||||||||||||||
| (Unaudited) | Revenue % Change | Volume / Product Mix Effect | Price Effect | Exchange Rate Effect | ||||||||||
| Advanced Materials | 9 | % | 10 | % | (2) | % | 1 | % | ||||||
| Additives & Functional Products | 12 | % | 11 | % | — | % | 1 | % | ||||||
| Chemical Intermediates | 18 | % | 17 | % | 1 | % | — | % | ||||||
| Fibers | (4) | % | (2) | % | (2) | % | — | % | ||||||
| Total Eastman Chemical Company | 10 | % | 10 | % | (1) | % | 1 | % | ||||||
Table 2C – Sales by Customer Location
| First Quarter | |||||||||||
| (Dollars in millions, unaudited) | 2026 | 2025 | |||||||||
| Sales by Customer Location | |||||||||||
| United States and Canada | $ | 979 | $ | 1,020 | |||||||
| Europe, Middle East, and Africa | 574 | 610 | |||||||||
| Asia Pacific | 500 | 539 | |||||||||
| Latin America | 124 | 121 | |||||||||
| Total Eastman Chemical Company | $ | 2,177 | $ | 2,290 | |||||||
3
Table 3A - Segment, Other, and Company
Non-GAAP Earnings (Loss) Before Interest and Taxes Reconciliations (1)
| First Quarter | ||||||||||||||
| (Dollars in millions, unaudited) | 2026 | 2025 | ||||||||||||
| Advanced Materials | ||||||||||||||
| Earnings before interest and taxes | $ | 60 | $ | 116 | ||||||||||
Cost of sales impact from restructuring activities (2) | 3 | — | ||||||||||||
Asset impairments, restructuring, and other charges, net (2) | 6 | — | ||||||||||||
| Excluding non-core items | 69 | 116 | ||||||||||||
| Additives & Functional Products | ||||||||||||||
| Earnings before interest and taxes | 142 | 137 | ||||||||||||
| Asset impairments, restructuring, and other charges, net | — | 4 | ||||||||||||
| Excluding non-core items | 142 | 141 | ||||||||||||
| Chemical Intermediates | ||||||||||||||
Earnings (loss) before interest and taxes | (18) | 19 | ||||||||||||
| Fibers | ||||||||||||||
| Earnings before interest and taxes | 45 | 88 | ||||||||||||
| Other | ||||||||||||||
| Loss before interest and taxes | (41) | (58) | ||||||||||||
Asset impairments, restructuring, and other charges net (3) | 3 | 5 | ||||||||||||
Excluding non-core items | (38) | (53) | ||||||||||||
| Total Eastman Chemical Company | ||||||||||||||
| Earnings before interest and taxes | 188 | 302 | ||||||||||||
Cost of sales impact from restructuring activities | 3 | — | ||||||||||||
Asset impairments, restructuring, and other charges, net | 9 | 9 | ||||||||||||
Total earnings before interest and taxes excluding non-core items | $ | 200 | $ | 311 | ||||||||||
| Company Non-GAAP Earnings Before Interest and Taxes Reconciliations by Line Items | ||||||||||||||
| Earnings before interest and taxes | $ | 188 | $ | 302 | ||||||||||
| Cost of sales impact from restructuring activities | 3 | — | ||||||||||||
| Asset impairments, restructuring, and other charges, net | 9 | 9 | ||||||||||||
Total earnings before interest and taxes excluding non-core items | $ | 200 | $ | 311 | ||||||||||
(1)See "Management's Discussion and Analysis of Financial Condition and Results of Operations" of the Quarterly Report on Form 10-Q for first quarter 2025 for description of first quarter 2025 non-core items.
(2)First three months 2026 included inventory adjustment charges of $3 million, severance charges of $3 million, and restructuring charges of $3 million related to the closure of a production line at a German performance films facility in the AM segment.
(3)First three months 2026 included severance charges of $3 million related to corporate cost reduction initiatives reported in "Other."
4
Table 3A - Segment, Other, and Company
Non-GAAP Earnings (Loss) Before Interest and Taxes Reconciliations (continued) (1)
| Fourth Quarter | ||||||||
| (Dollars in millions, unaudited) | 2025 | |||||||
| Advanced Materials | ||||||||
| Earnings before interest and taxes | $ | 41 | ||||||
Asset impairments, restructuring, and other charges, net | 18 | |||||||
| Excluding non-core items | 59 | |||||||
| Additives & Functional Products | ||||||||
| Earnings before interest and taxes | 94 | |||||||
| Chemical Intermediates | ||||||||
| Loss before interest and taxes | (50) | |||||||
Asset impairments, restructuring, and other charges, net | 9 | |||||||
| Environmental and other costs | 13 | |||||||
Excluding non-core items | (28) | |||||||
| Fibers | ||||||||
| Earnings before interest and taxes | 47 | |||||||
| Asset impairments, restructuring, and other charges, net | 2 | |||||||
| Excluding non-core items | 49 | |||||||
| Other | ||||||||
| Loss before interest and taxes | (68) | |||||||
Asset impairments, restructuring, and other charges net | 25 | |||||||
Mark-to-market pension and other postretirement benefit plans (gain) loss, net | (6) | |||||||
| Environmental and other costs | 9 | |||||||
Excluding non-core items | (40) | |||||||
| Total Eastman Chemical Company | ||||||||
| Earnings before interest and taxes | 64 | |||||||
Asset impairments, restructuring, and other charges, net | 54 | |||||||
Mark-to-market pension and other postretirement benefit plans (gain) loss, net | (6) | |||||||
| Environmental and other costs | 22 | |||||||
Total earnings before interest and taxes excluding non-core items | $ | 134 | ||||||
(1)For the description of fourth quarter 2025 non-core items, see Table 3A of the Quarterly Report on Form 8-K for fourth quarter 2025.
5
Table 3B - Segment Non-GAAP Earnings (Loss) Before Interest and Taxes Margins (1)(2)
| First Quarter | |||||||||||||||||
| 2026 | 2025 | ||||||||||||||||
| (Dollars in millions, unaudited) | Adjusted EBIT | Adjusted EBIT Margin | Adjusted EBIT | Adjusted EBIT Margin | |||||||||||||
| Advanced Materials | $ | 69 | 9.7 | % | $ | 116 | 16.1 | % | |||||||||
Additives & Functional Products | 142 | 19.2 | % | 141 | 19.2 | % | |||||||||||
Chemical Intermediates | (18) | (3.6) | % | 19 | 3.5 | % | |||||||||||
| Fibers | 45 | 20.0 | % | 88 | 30.6 | % | |||||||||||
Total segment EBIT excluding non-core items | 238 | 10.9 | % | 364 | 15.9 | % | |||||||||||
| Other | (38) | (53) | |||||||||||||||
Total EBIT excluding non-core items | $ | 200 | 9.2 | % | $ | 311 | 13.6 | % | |||||||||
| Fourth Quarter | ||||||||
| 2025 | ||||||||
| (Dollars in millions, unaudited) | Adjusted EBIT | Adjusted EBIT Margin | ||||||
| Advanced Materials | $ | 59 | 9.0 | % | ||||
Additives & Functional Products | 94 | 14.2 | % | |||||
Chemical Intermediates | (28) | (6.7) | % | |||||
| Fibers | 49 | 20.9 | % | |||||
Total segment EBIT excluding non-core items | 174 | 8.8 | % | |||||
Other | (40) | |||||||
Total EBIT excluding non-core items | $ | 134 | 6.8 | % | ||||
(1)For identification of excluded non-core items and reconciliations to GAAP EBIT, see Table 3A.
(2)Adjusted EBIT margin is non-GAAP EBIT divided by GAAP sales. See Table 2A for sales.
6
Table 4A – Non-GAAP Earnings Before Interest and Taxes, Net Earnings,
and Earnings Per Share Reconciliations
| First Quarter 2026 | ||||||||||||||||||||||||||||||||||||||
| Earnings Before Interest and Taxes | Earnings Before Income Taxes | Provision for Income Taxes | Effective Income Tax Rate | Net Earnings Attributable to Eastman | ||||||||||||||||||||||||||||||||||
| (Dollars in millions, except per share amounts, unaudited) | After Tax | Per Diluted Share | ||||||||||||||||||||||||||||||||||||
| As reported (GAAP) | $ | 188 | $ | 136 | $ | 29 | 21 | % | $ | 107 | $ | 0.93 | ||||||||||||||||||||||||||
Non-Core or Unusual Items: (1) | ||||||||||||||||||||||||||||||||||||||
Cost of sales impact from restructuring activities | 3 | 3 | 1 | 2 | 0.02 | |||||||||||||||||||||||||||||||||
Asset impairments, restructuring, and other charges, net | 9 | 9 | 3 | 6 | 0.05 | |||||||||||||||||||||||||||||||||
Income tax related item (2) | — | — | (5) | 5 | 0.04 | |||||||||||||||||||||||||||||||||
Interim adjustment to tax provision (3) | — | — | (5) | 5 | 0.05 | |||||||||||||||||||||||||||||||||
Non-GAAP (Excluding non-core and unusual items and with adjusted provision for income taxes) | $ | 200 | $ | 148 | $ | 23 | 15 | % | $ | 125 | $ | 1.09 | ||||||||||||||||||||||||||
| First Quarter 2025 | ||||||||||||||||||||||||||||||||||||||
| Earnings Before Interest and Taxes | Earnings Before Income Taxes | Provision for Income Taxes | Effective Income Tax Rate | Net Earnings Attributable to Eastman | ||||||||||||||||||||||||||||||||||
| (Dollars in millions, except per share amounts, unaudited) | After Tax | Per Diluted Share | ||||||||||||||||||||||||||||||||||||
| As reported (GAAP) | $ | 302 | $ | 253 | $ | 70 | 28 | % | $ | 182 | $ | 1.57 | ||||||||||||||||||||||||||
Non-Core Items: (1) | ||||||||||||||||||||||||||||||||||||||
Asset impairments, restructuring, and other charges, net | 9 | 9 | 1 | 8 | 0.06 | |||||||||||||||||||||||||||||||||
Interim adjustment to tax provision (3) | — | — | (32) | 32 | 0.28 | |||||||||||||||||||||||||||||||||
Non-GAAP (Excluding non-core items and with adjusted provision for income taxes) | $ | 311 | $ | 262 | $ | 39 | 16 | % | $ | 222 | $ | 1.91 | ||||||||||||||||||||||||||
(1)See Table 3A for description of first quarter 2026 and 2025 non-core items excluded from non-GAAP EBIT. Provision for income taxes for non-core items is calculated using the tax rate for the jurisdiction where the gains are taxable and the expenses are deductible.
(2)First quarter 2026 includes expense related to a prior tax law change.
(3)The adjusted provision for income taxes for first quarter 2026 and 2025 is calculated applying the forecasted full year effective tax rate as shown in Table 4B.
7
Table 4A – Non-GAAP Earnings Before Interest and Taxes, Net Earnings,
and Earnings Per Share Reconciliations (continued)
| Fourth Quarter 2025 | ||||||||||||||||||||||||||||||||||||||
| Earnings Before Interest and Taxes | Earnings Before Income Taxes | (Benefit from) Provision for Income Taxes | Effective Income Tax Rate | Net Earnings Attributable to Eastman | ||||||||||||||||||||||||||||||||||
| (Dollars in millions, except per share amounts, unaudited) | After Tax | Per Diluted Share | ||||||||||||||||||||||||||||||||||||
As reported (GAAP) (1) | $ | 64 | $ | 12 | $ | (71) | > (100%) | $ | 83 | $ | 0.72 | |||||||||||||||||||||||||||
Non-Core or Unusual Items: (2) | ||||||||||||||||||||||||||||||||||||||
Asset impairments, restructuring, and other charges, net | 54 | 54 | 10 | 44 | 0.38 | |||||||||||||||||||||||||||||||||
Mark-to-market pension and other postretirement benefit plans (gain) loss, net | (6) | (6) | (3) | (3) | (0.03) | |||||||||||||||||||||||||||||||||
| Environmental and other costs | 22 | 22 | 6 | 16 | 0.15 | |||||||||||||||||||||||||||||||||
Income tax related items (3) | — | — | (11) | 11 | 0.08 | |||||||||||||||||||||||||||||||||
Interim adjustment to tax provision (1)(4) | — | — | 64 | (64) | (0.55) | |||||||||||||||||||||||||||||||||
Non-GAAP (Excluding non-core and unusual items and with adjusted provision for income taxes) | $ | 134 | $ | 82 | $ | (5) | (5) | % | $ | 87 | $ | 0.75 | ||||||||||||||||||||||||||
(1)Fourth quarter 2025 provision for income tax and interim adjustment to tax provision have been revised by offsetting amounts as a result of a correction of an item in the third quarter 2025 provision for income tax. Full year 2025 provision for income taxes was not impacted.
(2)See Table 3A for description of fourth quarter 2025 non-core items excluded from non-GAAP EBIT. Provision for income taxes for non-core and unusual items is calculated using the tax rate for the jurisdiction where the gains are taxable and the expenses are deductible.
(3)Fourth quarter 2025 includes benefits related to prior tax law changes and a charge related to a valuation allowance driven by macroeconomic uncertainties related to certain deferred tax assets in the U.S.
(4)Fourth quarter 2025 is a reconciliation of the adjustments made to interim quarters to reflect the previously forecasted full year effective tax rate.
Table 4B - Adjusted Effective Tax Rate Calculation
First Three Months (1) | |||||||||||
(Unaudited) | 2026 | 2025 | |||||||||
| Effective tax rate | 21 | % | 28 | % | |||||||
Discrete tax items (2) | (1) | % | (2) | % | |||||||
Tax impact of current year non-core and unusual items (3) | (1) | % | 1 | % | |||||||
| Changes in tax contingencies and valuation allowances | 1 | % | (2) | % | |||||||
Forecasted full year impact of expected tax events (4) | (5) | % | (9) | % | |||||||
| Forecasted full year adjusted effective tax rate | 15 | % | 16 | % | |||||||
(1)Effective tax rate percentages are rounded to the nearest whole percent. The forecasted full year effective tax rates are 14.5 percent and 15.5 percent in first three months 2026 and 2025, respectively.
(2)"Discrete tax items" are items that are excluded from the Company's estimated annual effective tax rate and recognized entirely in the quarter in which the item occurs. Discrete tax items for first three months 2026 and 2025 are related to share based compensation expense and adjustments to certain prior year tax returns.
(3)Provision for income taxes for non-core and unusual items is calculated using the tax rate for the jurisdiction where the gains are taxable and the expenses are deductible.
(4)Expected future tax events may include finalization of tax returns; federal, state, and foreign examinations or the expiration of statutes of limitation; and corporate restructurings.
8
Table 5 – Statements of Cash Flows
| First Three Months | |||||||||||
| (Dollars in millions, unaudited) | 2026 | 2025 | |||||||||
| Operating activities | |||||||||||
| Net earnings | $ | 107 | $ | 183 | |||||||
| Adjustments to reconcile net earnings to net cash used in operating activities: | |||||||||||
| Depreciation and amortization | 131 | 126 | |||||||||
| Benefit from deferred income taxes | (5) | (3) | |||||||||
| Changes in operating assets and liabilities, net of effect of acquisitions and divestitures: | |||||||||||
| (Increase) decrease in trade receivables | (222) | (92) | |||||||||
| (Increase) decrease in inventories | (119) | (120) | |||||||||
| Increase (decrease) in trade payables | 67 | (72) | |||||||||
| Pension and other postretirement contributions (in excess of) less than expenses | (26) | (14) | |||||||||
| Variable compensation payments (in excess of) less than expenses | (49) | (109) | |||||||||
| Other items, net | (21) | (66) | |||||||||
Net cash used in operating activities | (137) | (167) | |||||||||
| Investing activities | |||||||||||
| Additions to properties and equipment | (103) | (147) | |||||||||
Government incentives | 3 | 11 | |||||||||
| Other items, net | (4) | 5 | |||||||||
Net cash used in investing activities | (104) | (131) | |||||||||
| Financing activities | |||||||||||
Net increase in commercial paper and other borrowings | — | 285 | |||||||||
| Proceeds from borrowings | 594 | 246 | |||||||||
| Repayment of borrowings | (150) | (550) | |||||||||
| Dividends paid to stockholders | (96) | (96) | |||||||||
| Other items, net | (7) | (9) | |||||||||
Net cash provided by (used in) financing activities | 341 | (124) | |||||||||
| Effect of exchange rate changes on cash and cash equivalents | (1) | 3 | |||||||||
| Net change in cash and cash equivalents | 99 | (419) | |||||||||
| Cash and cash equivalents at beginning of period | 566 | 837 | |||||||||
| Cash and cash equivalents at end of period | $ | 665 | $ | 418 | |||||||
Table 6 – Total Borrowings to Net Debt Reconciliations
| March 31, | December 31, | |||||||||||||
| (Dollars in millions, unaudited) | 2026 | 2025 | ||||||||||||
| Total borrowings | $ | 5,220 | $ | 4,787 | ||||||||||
| Less: Cash and cash equivalents | 665 | 566 | ||||||||||||
Net debt (1) | $ | 4,555 | $ | 4,221 | ||||||||||
(1)Includes non-cash decrease of $12 million in 2026 and a non-cash increase of $68 million in 2025 resulting from foreign currency exchange rates.
9
FAQ
How did Eastman (EMN) perform financially in first-quarter 2026?
Eastman reported Q1 2026 sales of $2,177 million, down 5% from 2025, with EBIT of $188 million. Diluted EPS was $0.93 versus $1.57 a year earlier, and adjusted EPS was $1.09 compared with $1.91, reflecting weaker spreads and volumes.
What were Eastman (EMN) segment trends in Q1 2026?
In Q1 2026, Advanced Materials sales decreased 1%, Additives & Functional Products rose 1%, Chemical Intermediates fell 9%, and Fibers declined 22%. Fibers weakness and lower Chemical Intermediates pricing were key headwinds, while Additives & Functional Products held margin at 19.2%.
What guidance did Eastman (EMN) give for Q2 2026 earnings?
Eastman projected second-quarter 2026 adjusted diluted EPS in the range of $1.70 to $1.90. This compares with Q1 2026 adjusted EPS of $1.09 and assumes improved volume/mix in specialties, better Chemical Intermediates spreads, and about $45 million of planned maintenance costs.
How is Eastman (EMN) managing pricing, costs, and capital in 2026?
For 2026, Eastman is implementing about $500 million of price increases and targeting $125–$150 million in net cost reductions. The company plans approximately $400 million of capital expenditures while maintaining an investment-grade balance sheet and continuing dividend payments to shareholders.
What was Eastman’s cash flow and net debt position in Q1 2026?
In Q1 2026, Eastman used $137 million in net cash for operating activities, an improvement from $167 million used in Q1 2025, partly due to working capital movements. Net debt was $4,555 million at March 31, 2026, based on total borrowings of $5,220 million and cash of $665 million.
How did regional sales for Eastman (EMN) change in Q1 2026?
Q1 2026 sales were $979 million in the United States and Canada, $574 million in Europe, Middle East and Africa, $500 million in Asia Pacific, and $124 million in Latin America. All major regions saw year-over-year declines in revenue compared with Q1 2025 levels.